Honma O, Watanabe C, Fukuchimoto H, Kashiwazaki J, Tateba M, Wagatsuma S, Ogata K, Maki K, Sonou H, Shiga K, Otsuka E, Hiruta M, Hirasawa Y, Hosonuma M, Murayama M, Narikawa Y, Toyoda H, Tsurui T, Kuramasu A, Kin M, Kubota Y, Sambe T, Horiike A, Ishida H, Shimada K, Umeda M, Tsunoda T, Yoshimura K
Department of Nursing, Showa University Hospital, Tokyo, Japan.
Department of Nursing, Showa University School of Nursing and Rehabilitation Sciences, Kanagawa, Japan.
Front Pharmacol. 2022 Feb 9;13:744916. doi: 10.3389/fphar.2022.744916. eCollection 2022.
Proper management of adverse events is crucial for the safe and effective implementation of anticancer drug treatment. Showa University Hospital uses our interview sheet (assessment and risk control [ARC] sheet) for the accurate evaluation of adverse events. On the day of anticancer drug treatment, a nurse conducts a face-to-face interview. As a feature of the ARC sheet, by separately describing the symptoms the day before treatment and the day of treatment and sharing the information on the medical record, it is possible to clearly determine the status of adverse events. In this study, we hypothesized that the usefulness and points for improvement of the ARC sheet would be clarified by using and evaluating a patient questionnaire. This study included 174 patients (144 at Showa University Hospital (Hatanodai Hospital) and 30 at Showa University Koto Toyosu Hospital (Toyosu Hospital) who underwent pre-examination interviews by nurses and received cancer chemotherapy at the outpatient center of Hatanodai and Toyosu Hospital. In the questionnaire survey, the ARC sheet's content and quality, respondents' satisfaction, structural strengths, and points for improvement were evaluated on a five-point scale. The patient questionnaire received responses from 160 participants, including the ARC sheet use group (132 people) and the non-use group (28 people). Unlike the ARC sheet non-use group, the ARC sheet use group recognized that the sheet was useful to understand the adverse events of aphthous ulcers ( = 0.017) and dysgeusia ( = 0.006). In the satisfaction survey questionnaire, there was a high sense of security in the pre-examination interviews by nurses using the ARC sheet. The ARC sheet is considered an effective tool for comprehensively evaluating adverse events. Pre-examination interviews by nurses using ARC sheets accurately determined the adverse events experienced by patients with anxiety and tension due to confrontation with physicians.
妥善管理不良事件对抗癌药物治疗的安全有效实施至关重要。昭和大学医院使用我们的访谈表（评估与风险控制[ARC]表）来准确评估不良事件。在进行抗癌药物治疗当天，护士会进行面对面访谈。ARC表的一个特点是，通过分别描述治疗前一天和治疗当天的症状并在病历上共享信息，可以清楚地确定不良事件的状况。在本研究中，我们假设通过使用和评估患者问卷可以阐明ARC表的实用性和改进要点。本研究纳入了174例患者（昭和大学医院（羽田医院）144例，昭和大学小田急丰洲医院（丰洲医院）30例），这些患者在羽田医院和丰洲医院门诊中心接受了护士的预检访谈并接受了癌症化疗。在问卷调查中，对ARC表的内容和质量、受访者满意度、结构优势和改进要点进行了五分制评估。患者问卷收到了160名参与者的回复，包括ARC表使用组（132人）和非使用组（28人）。与ARC表非使用组不同，ARC表使用组认识到该表有助于了解口腔溃疡（P = 0.017）和味觉障碍（P = 0.006）的不良事件。在满意度调查问卷中，使用ARC表的护士进行的预检访谈中安全感较高。ARC表被认为是全面评估不良事件的有效工具。使用ARC表的护士进行的预检访谈准确地确定了因与医生面谈而焦虑紧张的患者所经历的不良事件。
